Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 7
2004 3
2005 2
2006 4
2007 8
2008 4
2009 3
2010 11
2011 9
2012 8
2013 4
2014 5
2015 12
2016 10
2017 3
2018 9
2019 1
2020 5
2021 5
2022 7
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Effective intravenous delivery of adenovirus armed with TNFα and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancer.
Kudling TV, Clubb JHA, Pakola S, Quixabeira DCA, Lähdeniemi IAK, Heiniö C, Arias V, Havunen R, Cervera-Carrascon V, Santos JM, Sutinen E, Räsänen J, Borenius K, Mäyränpää MI, Aaltonen E, Sorsa S, Hemminki O, Kanerva A, Verschuren EW, Ilonen I, Hemminki A. Kudling TV, et al. Among authors: kanerva a. Oncoimmunology. 2023 Aug 2;12(1):2241710. doi: 10.1080/2162402X.2023.2241710. eCollection 2023. Oncoimmunology. 2023. PMID: 37546696 Free PMC article.
Adenoviruses for treatment of cancer.
Kanerva A, Hemminki A. Kanerva A, et al. Ann Med. 2005;37(1):33-43. doi: 10.1080/07853890410018934. Ann Med. 2005. PMID: 15902845 Review.
Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes.
Pikkusaari S, Tumiati M, Virtanen A, Oikkonen J, Li Y, Perez-Villatoro F, Muranen T, Salko M, Huhtinen K, Kanerva A, Koskela H, Tapper J, Koivisto-Korander R, Joutsiniemi T, Haltia UM, Lassus H, Hautaniemi S, Färkkilä A, Hynninen J, Hietanen S, Carpén O, Kauppi L. Pikkusaari S, et al. Among authors: kanerva a. Clin Cancer Res. 2023 Aug 15;29(16):3110-3123. doi: 10.1158/1078-0432.CCR-22-3156. Clin Cancer Res. 2023. PMID: 36805632 Free PMC article.
Gene transfer approaches for gynecological diseases.
Raki M, Rein DT, Kanerva A, Hemminki A. Raki M, et al. Among authors: kanerva a. Mol Ther. 2006 Aug;14(2):154-63. doi: 10.1016/j.ymthe.2006.02.019. Epub 2006 May 2. Mol Ther. 2006. PMID: 16650808 Free article. Review.
Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma.
Murumägi A, Ungureanu D, Khan S, Arjama M, Välimäki K, Ianevski A, Ianevski P, Bergström R, Dini A, Kanerva A, Koivisto-Korander R, Tapper J, Lassus H, Loukovaara M, Mägi A, Hirasawa A, Aoki D, Pietiäinen V, Pellinen T, Bützow R, Aittokallio T, Kallioniemi O. Murumägi A, et al. Among authors: kanerva a. Br J Cancer. 2023 Feb;128(4):678-690. doi: 10.1038/s41416-022-02067-z. Epub 2022 Dec 7. Br J Cancer. 2023. PMID: 36476658 Free PMC article.
Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting.
Clubb JHA, Kudling TV, Girych M, Haybout L, Pakola S, Hamdan F, Cervera-Carrascon V, Hemmes A, Grönberg-Vähä-Koskela S, Santos JM, Quixabeira DCA, Basnet S, Heiniö C, Arias V, Jirovec E, Kaptan S, Havunen R, Sorsa S, Erikat A, Schwartz J, Anttila M, Aro K, Viitala T, Vattulainen I, Cerullo V, Kanerva A, Hemminki A. Clubb JHA, et al. Among authors: kanerva a. Front Immunol. 2023 Feb 3;14:1060540. doi: 10.3389/fimmu.2023.1060540. eCollection 2023. Front Immunol. 2023. PMID: 36817448 Free PMC article.
Familial Ovarian Cancer Clusters with Other Cancers.
Zheng G, Yu H, Kanerva A, Försti A, Sundquist K, Hemminki K. Zheng G, et al. Among authors: kanerva a. Sci Rep. 2018 Aug 1;8(1):11561. doi: 10.1038/s41598-018-29888-4. Sci Rep. 2018. PMID: 30069056 Free PMC article.
Gene therapy of gynaecological diseases.
Kanerva A, Raki M, Hemminki A. Kanerva A, et al. Expert Opin Biol Ther. 2007 Sep;7(9):1347-61. doi: 10.1517/14712598.7.9.1347. Expert Opin Biol Ther. 2007. PMID: 17727325 Review.
Modified adenoviruses for cancer gene therapy.
Kanerva A, Hemminki A. Kanerva A, et al. Int J Cancer. 2004 Jul 1;110(4):475-80. doi: 10.1002/ijc.20129. Int J Cancer. 2004. PMID: 15122578 Free article. Review.
Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytes.
Zafar S, Quixabeira DCA, Kudling TV, Cervera-Carrascon V, Santos JM, Grönberg-Vähä-Koskela S, Zhao F, Aronen P, Heiniö C, Havunen R, Sorsa S, Kanerva A, Hemminki A. Zafar S, et al. Among authors: kanerva a. Cancer Gene Ther. 2021 May;28(5):442-454. doi: 10.1038/s41417-020-00226-z. Epub 2020 Sep 12. Cancer Gene Ther. 2021. PMID: 32920593 Free PMC article.
116 results